Diphenhydramine

This classification denotes a histamine-1 receptor antagonist and antiemetic agent with the molecular formula C17H21NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8GTS82S83M, chemically known as 2-(diphenylmethoxy)-n,n-dimethylethylamine hydrochloride but generally known as diphenhydramine, which bears US NIH Compound Identifier 3100. European Medicines Agency schedules Diphenhydramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07211MIG. The term DIPHENHYDRAMINE is an International Non-Proprietary Name. World Health Organization schedules diphenhydramine in its Anatomical Therapeutic Chemical (ATC) Classification. DIPHENHYDRAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diphenhydramine under HS 29221980 and SITC 51461. As of Q4 2014, DIPHENHYDRAMINE remains the US FDA Preferred Term for this commodity. Diphenhydramine bears US NLM identifiers UMLS ID C0012522 and NCI Concept Code C61728. SMILES: O(C(C1CCCCC1)C1CCCCC1)CCN(C)C.